Evidence map›Paper›PMID 10708420›Full record

ArticleJournal of virology2000

Hypervariable region 1 sequence stability during hepatitis C virus replication in chimpanzees.

S C Ray, Q Mao, R E Lanford, S Bassett, O Laeyendecker, Y M Wang, D L Thomas

Abstract read
In one paragraph

Article in Journal of virology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Adaptive immunity to the hepatitis C virus.Advances in virus research · 2010
    Review
  14. Genetic divergence of hepatitis C virus: the role of HIV-related immunosuppression.Journal of acquired immune deficiency syndromes (1999) · 2008
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

S C RayDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA. sray@jhmi.edu
Q Mao
R E Lanford
S Bassett
O Laeyendecker
Y M Wang
D L Thomas

Funding

WNV REPLIVAX VACCINE IN NON-HUMAN PRIMATESP51RR013986 · NCRR · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI DAVIS, MICHAEL DUFF · 1999 to 2011
$79.1M
Virus-Host Interactions in Hepatitis C Virus (HCV) InfectionsU19AI040035 · NIAID · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI RAY, STUART C · 1996 to 2009
$12.0M
NATURAL HISTORY OF HIV INFECTION IN INJECTION DRUG USERSR37DA004334 · NIDA · JOHNS HOPKINS UNIVERSITY · PI KIRK, GREGORY D · 1997 to 2006
$9.0M
THE NATURAL HISTORY OF HIV INFECTION AMONG DRUG USERSR01DA004334 · NIDA · JOHNS HOPKINS UNIVERSITY · PI KIRK, GREGORY D · 1987 to 2011
$7.6M
Natural History of HIV Infection In Injection Drug UsersR56DA004334 · NIDA · JOHNS HOPKINS UNIVERSITY · PI KIRK, GREGORY D · 2012 to 2013
$3.2M
Intramural NIH HHS Z99 AI999999NCRR NIH HHS P51 RR013986NCRR NIH HHS RR13986NIAID NIH HHS IU19 AI-40035NIAID NIH HHS N01 AI040035NIAID NIH HHS U19 AI040035NIDA NIH HHS DA04334NIDA NIH HHS R01 DA004334NIDA NIH HHS R37 DA004334NIDA NIH HHS R56 DA004334
6 · The paper itself

Abstract

The putative envelope 2 (E2) gene of hepatitis C virus (HCV) contains a highly variable region referred to as hypervariable region 1 (HVR1). We hypothesized that this genetic variability is driven by immune selection pressure, rather than representing the accumulation of random mutations in a region with relatively little functional constraint. To test this hypothesis, we examined the E2 sequence of a human inoculum that was passaged through eight chimpanzees, which appear to have a replicative rate (opportunity for chance mutation) similar to that of humans. Acute-phase plasma samples from a human (the inoculum) and six of eight serially infected chimpanzees were studied. For each, 33 cloned cDNAs were examined by a combined heteroduplex-single-stranded conformational polymorphism assay to assess quasispecies complexity and optimize selection of clones with unique gel shift patterns (clonotypes) for sequencing. The sequence diversity of HCV was significantly lower in the chimpanzees than in the humans, and during eight serial passages there was no change in the sequence of the majority clonotype from each animal examined. Similarly, the rates of protein sequence altering (nonsynonymous) substitution were lower in the chimpanzees than in the humans. These findings demonstrate that nonsynonymous mutations indicate selection pressure rather than being an incidental result of HCV replication.

Indexed as

MutationAmino Acid SequenceAnimalsBase SequenceCloning, MolecularDNA PrimersHepacivirusHumansMolecular Sequence DataPan troglodytesPhylogenyPolymorphism, Single-Stranded ConformationalSequence Homology, Amino AcidSerial PassageViral Envelope ProteinsVirus ReplicationDNA Primersglycoprotein E2, Hepatitis C virusViral Envelope Proteins

Identifiers

PMID10708420
PMCPMC111804

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.